Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monica Caliber

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Safety|September 10, 2019
Safety of testosterone therapy in men with prostate cancerAbraham Morgentaler, Monica Caliber
Current Opinion in Pharmacology|May 16, 2021
Testosterone therapy for prevention and reversal of type 2 diabetes in men with low testosteroneMonica Caliber, Farid Saad
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|January 18, 2019
Important lessons about testosterone therapy- weight loss vs. testosterone therapy for symptom resolution, classical vs. functional hypogonadism, and shortterm vs. lifelong testosterone therapyMonica Caliber, Geoff Hackett
Clinical Endocrinology|July 28, 2023
Men, testosterone and Covid-19Kristina Groti Antonic, Blaz Antonic, Monica Caliber, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|February 21, 2019
Long-term treatment with testosterone undecanoate injections in men with hypogonadism alleviates erectile dysfunction and reduces risk of major adverse cardiovascular events, prostate cancer, and mortalityFarid Saad, Monica Caliber, Gheorghe Doros, et al.
Diabetes Care|March 14, 2019
Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry StudyAksam Yassin, Ahmad Haider, Karim S Haider, et al.
Mayo Clinic Proceedings|February 1, 2015
Testosterone therapy and cardiovascular risk: advances and controversiesAbraham Morgentaler, Martin M Miner, Monica Caliber, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Safety|September 10, 2019
Safety of testosterone therapy in men with prostate cancerAbraham Morgentaler, Monica Caliber
Current Opinion in Pharmacology|May 16, 2021
Testosterone therapy for prevention and reversal of type 2 diabetes in men with low testosteroneMonica Caliber, Farid Saad
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|January 18, 2019
Important lessons about testosterone therapy- weight loss vs. testosterone therapy for symptom resolution, classical vs. functional hypogonadism, and shortterm vs. lifelong testosterone therapyMonica Caliber, Geoff Hackett
Clinical Endocrinology|July 28, 2023
Men, testosterone and Covid-19Kristina Groti Antonic, Blaz Antonic, Monica Caliber, et al.
The Aging Male : the Official Journal of the International Society for the Study of the Aging Male|February 21, 2019
Long-term treatment with testosterone undecanoate injections in men with hypogonadism alleviates erectile dysfunction and reduces risk of major adverse cardiovascular events, prostate cancer, and mortalityFarid Saad, Monica Caliber, Gheorghe Doros, et al.
Diabetes Care|March 14, 2019
Testosterone Therapy in Men With Hypogonadism Prevents Progression From Prediabetes to Type 2 Diabetes: Eight-Year Data From a Registry StudyAksam Yassin, Ahmad Haider, Karim S Haider, et al.
Mayo Clinic Proceedings|February 1, 2015
Testosterone therapy and cardiovascular risk: advances and controversiesAbraham Morgentaler, Martin M Miner, Monica Caliber, et al.
Pageof 1